28th September 2022
Acrisure has announced its acquisition of CRK Commercial Insurance Services Limited, the specialist commercial schemes provider. The deal is expected to close at the start of October 2022.
In the last nine years, Acrisure has completed or has under signed letter of intent more than 800 Partnerships globally, including nine in the UK. Established in 2000, CRK has grown into a highly successful broker in the manufacturing and engineering space under the leadership of its managing director, Darren Wills. CRK prides itself on having partnered with some of the largest insurers in the UK to establish exclusive insurance schemes with specialist covers and competitive rating structures to provide unique risk solutions for trades, with a focus on the manufacturing, engineering, rope access and HVAC industries.
Wills and his management team will continue to operate CRK under the CRK brand as part of Acrisure UK Retail. The CRK team will benefit from Acrisure’s technology capabilities and global network of brokers and MGA’s.
“I look forward to welcoming CRK to Acrisure,” said Mark McIlquham, president of Acrisure UK Retail. “We are excited to collaborate with CRK and Darren. CRK is a profoundly entrepreneurial and agile business with a fantastic client base. We were particularly attracted by the truly bespoke, unique schemes that the team have developed with their in-depth knowledge and understanding of specific trades and industries.”
Wills comments “Once I had met Mark and the Acrisure team, it was quickly apparent that the Acrisure model was perfect for me and CRK. Acrisure allows me to carry on running the business I am passionate about and have built up since 2000 as well as enables me to grow and diversify. I look forward to making CRK even more successful as part of Acrisure.”
Acrisure expects to make further announcements of new UK acquisitions and partnerships in the near term. It has continued to expand globally in 2022, with operations now in 15 countries. The company recently closed $725m in Series B-2 Preferred Equity and received a $23bn valuation, representing a 31% increase from its last preferred equity raise in March 2021.
Acrisure Trends(7 articles)